UK and India join forces to tackle the global health needs of women and children
26 Jul 2018
Seven research partnerships will receive a total of £10 million under Phase 2 of the Global Research Programme on Health between UKRI (led by the MRC and Economic and Social Research Council), Department for International Development and India’s Department of Biotechnology, under the Newton-Bhabha Fund.
The multidisciplinary research teams will lead projects that seek to address the health needs of women and children in disadvantaged populations globally. The awards will generate new evidence on interventions to tackle diseases that disproportionately affect women and their unborn children in low and middle-income countries, such as gestational diabetes mellitus, anaemia, hypertension and sexually transmitted diseases.
These collaborative awards form the second phase of the Global Research Programme on health, an initiative that brings together a consortium of funders to collectively support partnerships between researchers from the UK, India and low and middle-income countries (LMIC).
The partner agencies share the view that to have maximum impact on health we need to work together to provide evidence of the best and most appropriate interventions to improve health in LMIC settings. Pooling resources brings the necessary funds and experience together to achieve implementable results which address health problems affecting people in LMIC.
The projects will see research groups in Ethiopia, Uganda, the Gambia, Zambia and Nepal team up with researchers in India and the UK to ensure that results are implementable, scalable and in line with local policy needs, while also building capacity in these countries.
Alex Harris, International Programme Manager at the MRC, said: "Maternal and neonatal health represents a major global health challenge. Every year, worldwide, 2.7 million babies die during the first 28 days of life and 99% of all maternal deaths occur in developing countries. Creating environments for healthy pregnancies and infant development is a major priority for global health research. This exciting initiative that will see the UK and India join forces to tackle this key global health challenge."
The following studies have now been awarded through the second phase of the initiative:
- Pregnancy Interventions In Mothers Relating to Diabetes In Asian India and Low-income countries (The PRIMORDIAL Study)
UK lead: Fredrik Karpe, Oxford University
Indian lead: Jiji Mathews, Christian Medical College
- Generating epidemiological, economic and attitudinal evidence to inform policy-making about HPV vaccine introduction in India and Ethiopia
UK lead: Edward Mulholland, London School of Hygiene and Tropical Medicine
Indian lead: Dr Narendea K Arora, The INCLEN Trust International
- A cluster randomized trial of an mHealth integrated model of hypertension, diabetes and antenatal care in primary care settings in India and Nepal
UK lead: Oona Campbell, London School of Hygiene and Tropical Medicine
Indian lead: Prof D Prabhakaran, Public Health Foundation of India
- Comprehensive Anaemia Programme and Personalized Therapies (CAPPT)
UK lead: Sara Hillman, University College London
Indian lead: Vatsla Dadhwal, All India Institute of Medical Sciences
- CRADLE-4: Can Reduction of Adverse pregnancy outcomes occur with planned DeLivery vs.Expectant management in pre-eclampsia
UK lead: Andrew Shennan, King’s College London
Indian lead: Shivaprasad S Goudar, KLE University’s Jawaharlal Nehru Medical College
- Gestational diabetes in Uganda and India: Design and Evaluation of Educational Films for improving Screening and Self-management (GUIDES)
UK lead: Sanjay Kinra, London School of Hygiene and Tropical Medicine
Indian lead: Giridhara R Babu, Indian Institute of Public Health
- A randomised controlled trial to compare two different doses of maternal B12 supplementation in improving infant B12 deficiency and neurodevelopment
UK lead: Monica Lakhanpaul, University College London
Indian lead: Jitender Nagal, Sitaram Bhartia Inst of Science & Research.